Oppenheimer Upgrades Incyte (INCY) to Outperform

October 30, 2026 2:31 AM EDT Send to a Friend
Oppenheimer analyst Jay Olson upgraded Incyte (NASDAQ: INCY) from Perform to Outperform with a price target of $144.00 (from $120.00).The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login